These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

241 related items for PubMed ID: 22341583

  • 1. How to treat refractory arthritis in lupus?
    Artifoni M, Puéchal X.
    Joint Bone Spine; 2012 Jul; 79(4):347-50. PubMed ID: 22341583
    [Abstract] [Full Text] [Related]

  • 2. [Allergo-immunology. Clinical immunology].
    Chizzolini C.
    Rev Med Suisse; 2012 Jan 11; 8(323):11-3. PubMed ID: 22303732
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G, Danza A, Khamashta M.
    Med Clin (Barc); 2013 Dec 21; 141(12):533-42. PubMed ID: 23622892
    [Abstract] [Full Text] [Related]

  • 4. [What's new in internal medicine: emerging treatments for systemic lupus erythematosus].
    Hachulla É.
    Ann Dermatol Venereol; 2011 Dec 21; 138 Suppl 4():S241-4. PubMed ID: 22202645
    [Abstract] [Full Text] [Related]

  • 5. Management of RA medications in pregnant patients.
    Østensen M, Förger F.
    Nat Rev Rheumatol; 2009 Jul 21; 5(7):382-90. PubMed ID: 19506586
    [Abstract] [Full Text] [Related]

  • 6. Association of systemic lupus erythematosus standard of care immunosuppressants with glucocorticoid use and disease outcomes: a multicentre cohort study.
    de Luca Montes RA, Huq M, Godfrey T, Oon S, Calderone A, Kandane-Rathnayake R, Louthrenoo W, Luo SF, Jan Wu YJ, Golder V, Lateef A, Navarra SV, Zamora L, Hamijoyo L, Sockalingam S, An Y, Li Z, Katsumata Y, Harigai M, Chan M, Goldblatt F, O'Neill S, Lau CS, Cho J, Hoi A, Karyekar CS, Morand EF, Nikpour M.
    Adv Rheumatol; 2024 May 08; 64(1):38. PubMed ID: 38720354
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapies in rheumatologic disorders.
    Miller AV, Ranatunga SK.
    Med Clin North Am; 2012 May 08; 96(3):475-96, ix-x. PubMed ID: 22703852
    [Abstract] [Full Text] [Related]

  • 8. Biologics in SLE: towards new approaches.
    van Vollenhoven RF, Parodis I, Levitsky A.
    Best Pract Res Clin Rheumatol; 2013 Jun 08; 27(3):341-9. PubMed ID: 24238691
    [Abstract] [Full Text] [Related]

  • 9. New developments in the treatment of systemic lupus erythematosus.
    Tullus K.
    Pediatr Nephrol; 2012 May 08; 27(5):727-32. PubMed ID: 21516516
    [Abstract] [Full Text] [Related]

  • 10. New treatment strategy including biological agents in patients with systemic lupus erythematosus.
    Leszczyński P, Pawlak-Buś K.
    Pol Arch Med Wewn; 2013 May 08; 123(9):482-90. PubMed ID: 23828116
    [Abstract] [Full Text] [Related]

  • 11. Clinical assessment and management of cytopenias in lupus patients.
    Levine AB, Erkan D.
    Curr Rheumatol Rep; 2011 Aug 08; 13(4):291-9. PubMed ID: 21503695
    [Abstract] [Full Text] [Related]

  • 12. [New ways in the management of rheumatoid arthritis in Hungary].
    Gergely P, Poór G.
    Lege Artis Med; 2007 Oct 08; 17(10):657-64. PubMed ID: 19227595
    [Abstract] [Full Text] [Related]

  • 13. Research and therapeutics-traditional and emerging therapies in systemic lupus erythematosus.
    Davis LS, Reimold AM.
    Rheumatology (Oxford); 2017 Apr 01; 56(suppl_1):i100-i113. PubMed ID: 28375452
    [Abstract] [Full Text] [Related]

  • 14. Treatment of mild, moderate, and severe lupus erythematosus: focus on new therapies.
    Dall'era M, Chakravarty EF.
    Curr Rheumatol Rep; 2011 Aug 01; 13(4):308-16. PubMed ID: 21584692
    [Abstract] [Full Text] [Related]

  • 15. Etanercept in refractory lupus arthritis: An observational study.
    Cortés-Hernández J, Egri N, Vilardell-Tarrés M, Ordi-Ros J.
    Semin Arthritis Rheum; 2015 Jun 01; 44(6):672-9. PubMed ID: 25712812
    [Abstract] [Full Text] [Related]

  • 16. Is there still a role for abatacept in the treatment of lupus?
    Hoi A, Littlejohn G.
    Expert Opin Biol Ther; 2014 Sep 01; 14(9):1345-50. PubMed ID: 25005704
    [Abstract] [Full Text] [Related]

  • 17. Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus.
    Ikeda K, Sanayama Y, Makita S, Hosokawa J, Yamagata M, Nakagomi D, Takabayashi K, Nakajima H.
    Clin Dev Immunol; 2013 Sep 01; 2013():697525. PubMed ID: 24324510
    [Abstract] [Full Text] [Related]

  • 18. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
    Trindade VC, Carneiro-Sampaio M, Bonfa E, Silva CA.
    Paediatr Drugs; 2021 Jul 01; 23(4):331-347. PubMed ID: 34244988
    [Abstract] [Full Text] [Related]

  • 19. Management of non-renal non-neurologic persistent lupus activity in real world patients from Argentina.
    Scolnik M, Scaglioni V, Pons-Estel GJ, Soriano ER.
    Lupus; 2019 Aug 01; 28(9):1167-1173. PubMed ID: 31299882
    [Abstract] [Full Text] [Related]

  • 20. [Diagnosis and management of small vessel vasculitides].
    Pettersson T, Karjalainen A.
    Duodecim; 2010 Aug 01; 126(12):1496-507. PubMed ID: 20617753
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.